2.
The PFS and OS of patients with one extranodal involvement site (N=157)
| Extranodal involvement site | n | 3-year PFS (%) | 3-year OS (%) |
| PFS, progression-free survival; OS, overall survival; GI, gastrointestinal. | |||
| Waldeyer’s ring | 43 | 81.1±6.0 | 88.0±5.0 |
| Thyroid | 9 | 77.8±13.9 | 88.9±10.5 |
| Salivary gland | 4 | 75.0±21.7 | 100 |
| GI tract | 49 | 68.9±6.7 | 74.6±6.4 |
| Liver | 3 | 66.7±27.2 | 66.7±27.2 |
| Pancreas | 3 | 66.7±27.2 | 66.7±27.2 |
| Bone | 11 | 54.5±15.0 | 72.7±13.4 |
| Breast | 9 | 55.6±16.6 | 66.7±15.7 |
| Female genital tract | 5 | 60.0±21.9 | 60.0±21.9 |
| Thorax | 6 | 50.0±20.4 | 50.0±20.4 |
| Paranasal sinuses | 6 | 50.0±20.4 | 50.0±20.4 |
| Bone marrow | 6 | 41.7±22.2 | 50.0±20.4 |
| Brain | 3 | 0 | 0 |